sildenafil-citrate and Ebstein-Anomaly

sildenafil-citrate has been researched along with Ebstein-Anomaly* in 1 studies

Other Studies

1 other study(ies) available for sildenafil-citrate and Ebstein-Anomaly

Article	Year
Sildenafil use in a symptomatic neonate with severe Ebstein's anomaly of the tricuspid valve. American journal of perinatology, 2008, Volume: 25, Issue:2 Ebstein's anomaly (EA) is associated with poor outcome in symptomatic neonates. Management typically includes prostaglandins or surgical creation of a Blalock-Taussig shunt. Right ventricular afterload reduction may help by improving the forward flow across the pulmonary valve. We report the successful use of oral sildenafil, a pulmonary vasodilator, in a neonate with severe EA. Topics: Alprostadil; Ebstein Anomaly; Echocardiography; Female; Humans; Infant, Newborn; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents	2008

Article

Year

Sildenafil use in a symptomatic neonate with severe Ebstein's anomaly of the tricuspid valve.

American journal of perinatology, 2008, Volume: 25, Issue:2

Ebstein's anomaly (EA) is associated with poor outcome in symptomatic neonates. Management typically includes prostaglandins or surgical creation of a Blalock-Taussig shunt. Right ventricular afterload reduction may help by improving the forward flow across the pulmonary valve. We report the successful use of oral sildenafil, a pulmonary vasodilator, in a neonate with severe EA.

Topics: Alprostadil; Ebstein Anomaly; Echocardiography; Female; Humans; Infant, Newborn; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents

2008